FIELD: medicine, pharmaceutics.
SUBSTANCE: application of isonicotinoylhydrazide phthalate is proposed for lowering free fatty acids, cholesterol, and triglycerides levels. Decreasing of blood beta-lipoproteins concentration is shown in lab animals both intact and against diabetes background.
EFFECT: finding the means for lowering free fatty acids, cholesterol, and triglycerides levels basing on isonicotinoylhydrazide phthalate.
12 tbl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
HYPOGLYCEMIC AGENT | 2008 |
|
RU2385717C1 |
CITRACONIC ACID ISONICOTINOYLHYDRAZIDE ELICITING HYPOGLYCAEMIC ACTIVITY | 2000 |
|
RU2183625C2 |
PHTHALIC ACID ISONICOTINOYL HYDRAZIDE ELICITING HYPOGLYCEMIC ACTIVITY | 2002 |
|
RU2228753C2 |
HAEMORHEOLOGIC AGENT CAPABLE OF REDUCING INSULING RESISTANCE AND RESTORING BODY TOLERANCE TO GLUCOSE AND PHARMACEUTICAL COMPOSITION BASED ON SAID AGENT | 2007 |
|
RU2386634C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TYPE 2 DIABETES MELLITUS AND MEDICINE ON ITS BASIS | 2009 |
|
RU2435593C2 |
PHARMACEUTICAL COMPOSITIONS | 2010 |
|
RU2532330C2 |
SOLID DOSED FORMULATION FOR TREATMENT OF PANCREATIC DIABETES | 2006 |
|
RU2333760C2 |
ANTIDIABETIC PHARMACEUTICAL COMPOSITION IN THE FORM OF SACHET | 2023 |
|
RU2817200C1 |
COMBINATION FOR TREATMENT OF DIABETES AND COMPLICATIONS THEREOF | 2011 |
|
RU2451506C1 |
PANCREATIC DIABETES DRUG | 2004 |
|
RU2358738C2 |
Authors
Dates
2008-08-20—Published
2006-05-24—Filed